ABCG2- and ABCB1 Inhibition Using Supratherapeutic Doses of Erlotinib: Clinical Implications in the Treatment of Central Nervous System Metastases

Eveline A. van de Stadt, Maqsood Yaqub, Idris Bahce, N. H. Hendrikse

Research output: Contribution to journalLetterAcademicpeer-review

Original languageEnglish
Pages (from-to)305
Number of pages1
JournalJournal of nuclear medicine : official publication, Society of Nuclear Medicine
Issue number2
Early online date4 Oct 2019
Publication statusPublished - 1 Feb 2020

Cite this